Second Line Capital’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$591K	Sell	63,027 -16,672	-21%	-$156K	0.14%	64
2025 Q1	$567K	Sell	79,699 -51,423	-39%	-$366K	0.15%	65
2024 Q4	$1.53M	Buy	+131,122	New	+$1.53M	0.41%	42